| |
| |
| |
| Historical principles and perspectives | |
| |
| |
| |
| |
| Antiquated antidotes | |
| |
| |
| |
| |
| Toxicologic plagues and disasters in history | |
| |
| |
| |
| |
| Initial evaluation of the patient : vital signs and toxic syndromes | |
| |
| |
| |
| |
| Principles of managing the poisoned or overdosed patient | |
| |
| |
| |
| |
| Electrocardiographic principles | |
| |
| |
| |
| |
| Diagnostic imaging | |
| |
| |
| |
| |
| Laboratory principles | |
| |
| |
| |
| |
| Techniques used to prevent gastrointestinal absorption | |
| |
| |
| |
| |
| Syrup of ipecac | |
| |
| |
| |
| |
| Activated charcoal | |
| |
| |
| |
| |
| Whole-bowel irrigation and other intestinal evacuants | |
| |
| |
| |
| |
| Pharmacokinetic and toxicokinetic principles | |
| |
| |
| |
| |
| Principles and techniques applied to enhance elimination | |
| |
| |
| |
| |
| Use of the intensive care unit | |
| |
| |
| |
| |
| Chemical principles | |
| |
| |
| |
| |
| Biochemical and metabolic principles | |
| |
| |
| |
| |
| Neurotransmitters and neuromodulators | |
| |
| |
| |
| |
| Withdrawal principles | |
| |
| |
| |
| |
| Thermoregulatory principles | |
| |
| |
| |
| |
| Fluid, electrolyte, and acid-base principles | |
| |
| |
| |
| |
| Psychiatric principles | |
| |
| |
| |
| |
| Neurologic principles | |
| |
| |
| |
| |
| Ophthalmic principles | |
| |
| |
| |
| |
| Otolaryngologic principles | |
| |
| |
| |
| |
| Respiratory principles | |
| |
| |
| |
| |
| Cardiovascular principles | |
| |
| |
| |
| |
| Hematologic principles | |
| |
| |
| |
| |
| Gastrointestinal principles | |
| |
| |
| |
| |
| Hepatic principles | |
| |
| |
| |
| |
| Renal principles | |
| |
| |
| |
| |
| Genitourinary principles | |
| |
| |
| |
| |
| Dermatologic principles | |
| |
| |
| |
| |
| Reproductive and perinatal principles | |
| |
| |
| |
| |
| Pediatric principles | |
| |
| |
| |
| |
| Geriatric principles | |
| |
| |
| |
| |
| Postmortem toxicology | |
| |
| |
| |
| |
| Special considerations : organ procurement from poisoned patients | |
| |
| |
| |
| |
| Acetaminophen | |
| |
| |
| |
| |
| N-acetylcysteine | |
| |
| |
| |
| |
| Salicylates | |
| |
| |
| |
| |
| Sodium bicarbonate | |
| |
| |
| |
| |
| Nonsteroidal antiinflammatory drugs | |
| |
| |
| |
| |
| Colchicine and podophyllin | |
| |
| |
| |
| |
| Opioids | |
| |
| |
| |
| |
| Opioid antagonists | |
| |
| |
| |
| |
| Dieting agents and regimens | |
| |
| |
| |
| |
| Iron | |
| |
| |
| |
| |
| Deferoxamine | |
| |
| |
| |
| |
| Vitamins | |
| |
| |
| |
| |
| Essential oils | |
| |
| |
| |
| |
| Herbal preparations | |
| |
| |
| |
| |
| Athletic performance enhancers | |
| |
| |
| |
| |
| Food poisoning | |
| |
| |
| |
| |
| Botulism | |
| |
| |
| |
| |
| Botulinum antitoxin | |
| |
| |
| |
| |
| Anticonvulsants | |
| |
| |
| |
| |
| L-carnitine | |
| |
| |
| |
| |
| Antidiabetics and hypoglycemics | |
| |
| |
| |
| |
| Dextrose | |
| |
| |
| |
| |
| Octreotide | |
| |
| |
| |
| |
| Thyroid and antithyroid medications | |
| |
| |
| |
| |
| Antihistamines and decongestants | |
| |
| |
| |
| |
| Physostigmine salicylate | |
| |
| |
| |
| |
| Antimigraine medications | |
| |
| |
| |
| |
| Antineoplastics | |
| |
| |
| |
| |
| Leucovorin (folinic acid) and folic acid | |
| |
| |
| |
| |
| Pharmaceutical additives | |
| |
| |
| |
| |
| Antibiotics, antifungals, and antivirals | |
| |
| |
| |
| |
| Antituberculous medications | |
| |
| |
| |
| |
| Pyridoxine | |
| |
| |
| |
| |
| Antimalarials | |
| |
| |
| |
| |
| Anticoagulants | |
| |
| |
| |
| |
| Vitamin K[subscript 1] | |
| |
| |
| |
| |
| Protamine | |
| |
| |
| |
| |
| Calcium channel blockers | |
| |
| |
| |
| |
| [beta]-adrenergic antagonists | |
| |
| |
| |
| |
| Glucagon | |
| |
| |
| |
| |
| Other antihypertensives | |
| |
| |
| |
| |
| Antidysrhythmics | |
| |
| |
| |
| |
| Cardioactive steroids | |
| |
| |
| |
| |
| Digoxin-specific antibody fragments (fab) | |
| |
| |
| |
| |
| Methylxanthines and selective [beta][subscript 2]-adrenergic agonists | |
| |
| |
| |
| |
| Local anesthetics | |
| |
| |
| |
| |
| Inhalational anesthetics | |
| |
| |
| |
| |
| Neuromuscular blockers | |
| |
| |
| |
| |
| Dantrolene sodium | |
| |
| |
| |
| |
| Antipsychotics | |
| |
| |
| |
| |
| Lithium | |
| |
| |
| |
| |
| Monoamine oxidase inhibitors | |
| |
| |
| |
| |
| Serotonin reuptake inhibitors and atypical antidepressants | |
| |
| |
| |
| |
| Cyclic antidepressants | |
| |
| |
| |
| |
| Sedative-hypnotics | |
| |
| |
| |
| |
| Flumazenil | |
| |
| |
| |
| |
| Amphetamines | |
| |
| |
| |
| |
| Cocaine | |
| |
| |
| |
| |
| Ethanol | |
| |
| |
| |
| |
| Thiamine hydrochloride | |
| |
| |
| |
| |
| Ethanol withdrawal | |
| |
| |
| |
| |
| Disulfiram and disulfiramlike reactions | |
| |
| |
| |
| |
| [gamma]-hydroxybutyric acid | |
| |
| |
| |
| |
| Inhalants | |
| |
| |
| |
| |
| Hallucinogens | |
| |
| |
| |
| |
| Cannabinoids | |
| |
| |
| |
| |
| Nicotine and tobacco preparations | |
| |
| |
| |
| |
| Phencyclidine and ketamine | |
| |
| |
| |
| |
| Antimony | |
| |
| |
| |
| |
| Arsenic | |
| |
| |
| |
| |
| Dimercaprol (British anti-lewisite or BAL) | |
| |
| |
| |
| |
| Bismuth | |
| |
| |
| |
| |
| Cadmium | |
| |
| |
| |
| |
| Chromium | |
| |
| |
| |
| |
| Cobalt | |
| |
| |
| |
| |
| Copper | |
| |
| |
| |
| |
| Lead | |
| |
| |
| |
| |
| Succimer (2,3-dimercaptosuccinic acid) | |
| |
| |
| |
| |
| Edetate calcium disodium (CaNa[subscript 2]EDTA) | |
| |
| |
| |
| |
| Mercury | |
| |
| |
| |
| |
| Nickel | |
| |
| |
| |
| |
| Selenium | |
| |
| |
| |
| |
| Silver | |
| |
| |
| |
| |
| Thallium | |
| |
| |
| |
| |
| Prussian blue | |
| |
| |
| |
| |
| Zinc | |
| |
| |
| |
| |
| Antiseptics, disinfectants, and sterilants | |
| |
| |
| |
| |
| Camphor and moth repellents | |
| |
| |
| |
| |
| Caustics | |
| |
| |
| |
| |
| Hydrofluoric acid and fluorides | |
| |
| |
| |
| |
| Calcium | |
| |
| |
| |
| |
| Hydrocarbons | |
| |
| |
| |
| |
| Toxic alcohols | |
| |
| |
| |
| |
| Fomepizole | |
| |
| |
| |
| |
| Ethanol | |
| |
| |
| |
| |
| Pesticides : an overview with a focus on principles and rodenticides | |
| |
| |
| |
| |
| Barium | |
| |
| |
| |
| |
| Sodium monofluoracetate and fluoroacetamide | |
| |
| |
| |
| |
| Phosphorus | |
| |
| |
| |
| |
| Strychnine | |
| |
| |
| |
| |
| Insecticides : organic phosphorus compounds and carbamates | |
| |
| |
| |
| |
| Pralidoxime | |
| |
| |
| |
| |
| Atropine | |
| |
| |
| |
| |
| Insecticides : organic chlorines, pyrethrins/pyrethroids, and DEET | |
| |
| |
| |
| |
| Herbicides | |
| |
| |
| |
| |
| Methyl bromide and other fumigants | |
| |
| |
| |
| |
| Mushrooms | |
| |
| |
| |
| |
| Plants | |
| |
| |
| |
| |
| Arthropods | |
| |
| |
| |
| |
| Antivenom (scorpion and spider) | |
| |
| |
| |
| |
| Marine envenomations | |
| |
| |
| |
| |
| Snakes and other reptiles | |
| |
| |
| |
| |
| Antivenom (crotaline and elapid) | |
| |
| |
| |
| |
| Industrial poisoning : information and control | |
| |
| |
| |
| |
| Simple asphyxiants and pulmonary irritants | |
| |
| |
| |
| |
| Carbon monoxide | |
| |
| |
| |
| |
| Hyperbaric oxygen | |
| |
| |
| |
| |
| Cyanide and hydrogen sulfide | |
| |
| |
| |
| |
| Sodium and amyl nitrites | |
| |
| |
| |
| |
| Sodium thiosulfate | |
| |
| |
| |
| |
| Hydroxocobalamin | |
| |
| |
| |
| |
| Methemoglobin inducers | |
| |
| |
| |
| |
| Methylene blue | |
| |
| |
| |
| |
| Smoke inhalation | |
| |
| |
| |
| |
| Risk assessment and risk communication | |
| |
| |
| |
| |
| Hazmat incident response | |
| |
| |
| |
| |
| Chemical weapons | |
| |
| |
| |
| |
| Biological weapons | |
| |
| |
| |
| |
| Radiation | |
| |
| |
| |
| |
| Poison prevention and education | |
| |
| |
| |
| |
| Poison information centers and poison epidemiology | |
| |
| |
| |
| |
| International perspectives in medical toxicology | |
| |
| |
| |
| |
| Principles of epidemiology and research design | |
| |
| |
| |
| |
| Adverse drug events and postmarketing surveillance | |
| |
| |
| |
| |
| Medications, errors, and patient safety | |
| |
| |
| |
| |
| Risk management and legal principles | |
| |